Lu Chen

No. 415, Fengyang Road
Huangpu, 200003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction: The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.

Correction: The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.

Journal: Medical oncology (Northwood, London, England)

Published: July 28, 2026

Editorial Expression of Concern: Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells.

Editorial Expression of Concern: Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells.

Journal: Molecular and cellular biochemistry

Published: July 17, 2026

Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer.

Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer.

Journal: Cancer cell

Published: May 13, 2025

Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.

Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.

Journal: International journal of oncology

Published: January 20, 2017

SMC1A promotes growth and migration of prostate cancer in vitro and in vivo.

SMC1A promotes growth and migration of prostate cancer in vitro and in vivo.

Journal: International journal of oncology

Published: July 04, 2016

Natural Flavonoids as Promising Analgesic Candidates: A Systematic Review.

Natural Flavonoids as Promising Analgesic Candidates: A Systematic Review.

Journal: Chemistry & biodiversity

Published: March 04, 2016

Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation.

Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation.

Journal: Oncotarget

Published: January 15, 2016

Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy.

Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy.

Journal: Oncology reports

Published: July 07, 2015

[Corrigendum] Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy.

[Corrigendum] Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy.

Journal: Oncology reports

Published: July 07, 2015

Knockdown of GPR137,G Protein-coupled receptor 137, Inhibits the Proliferation and Migration of Human Prostate Cancer Cells.

Knockdown of GPR137,G Protein-coupled receptor 137, Inhibits the Proliferation and Migration of Human Prostate Cancer Cells.

Journal: Chemical biology & drug design

Published: May 19, 2015

The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.

The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.

Journal: Medical oncology (Northwood, London, England)

Published: February 05, 2015

Positive nin one binding protein expression predicts poor outcome in prostate cancer.

Positive nin one binding protein expression predicts poor outcome in prostate cancer.

Journal: Molecular medicine reports

Published: December 03, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026